Increased Antimicrobial Resistance among Sputum Pathogens from Patients with Hyperglycemia

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• Group IDFDA. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract. 2015;109(3):461–465. doi:10.1016/j.diabres.2015.05.03726119773
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959. doi:10.1001/jama.2013.16811824002281
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010 a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):27. doi:10.1016/S0140-6736(12)61689-4
   Web of Science ®Google Scholar
• Lepper PM, Ott S, Nuesch E, et al. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012;344:e3397. doi:10.1136/bmj.e339722645184
   PubMed Web of Science ®Google Scholar
• Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–289. doi:10.1136/thx.2005.05102916449265
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, AE K. Hyperglycemia an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):5. doi:10.1210/jcem.87.3.8341
   Web of Science ®Google Scholar
• Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:2475067. doi:10.1155/2016/247506727274985
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24:5. doi:10.3390/molecules24050892
   Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, et al. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. 2017;65(4):644–652. doi:10.1093/cid/cix41128472416
   PubMed Web of Science ®Google Scholar
• Neidell MJ, Cohen B, Furuya Y, et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807–815. doi:10.1093/cid/cis55222700828
   PubMed Web of Science ®Google Scholar
• Mauldin PD, Salgado CD, Hansen IS, et al. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother. 2010;54(1):109–115. doi:10.1128/AAC.01041-0919841152
   PubMed Web of Science ®Google Scholar
• Tian LT, Yao K, Zhang XY, et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect. 2012;18(9):E314–30. doi:10.1111/j.1469-0691.2012.03912.x22676078
   PubMed Web of Science ®Google Scholar
• Tian L, Tan R, Chen Y, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016;5:48. doi:10.1186/s13756-016-0145-027891222
   PubMed Web of Science ®Google Scholar
• American Diabetes A2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27.29222373
   PubMed Web of Science ®Google Scholar
• http://www.diabetesatlas.org.
   Google Scholar
• Gupta N, Limbago BM, Patel JB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir20221653305
   PubMed Web of Science ®Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–14. doi:10.1016/j.cmi.2016.01.00127000156
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707. doi:10.1128/CMR.05035-1123034326
   PubMed Web of Science ®Google Scholar
• Pogue JM, Mann T, Barber KE, Carbapenem-resistant KSK. Acinetobacter baumannii epidemiology, surveillance and management. Expert Rev Anti Infect Ther. 2013;11((4:383–393. doi:10.1586/eri.13.1423566148
   PubMed Web of Science ®Google Scholar
• Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568–585. doi:10.1016/j.ijantimicag.2015.03.00125857949
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.17278083
   PubMed Web of Science ®Google Scholar
• Smit J, Søgaard M, Schønheyder HC, Nielsen H, Frøslev T, RW T. Diabetes and risk of community-acquired Staphylococcus aureus bacteremia A population-based case-control study. Eur J Endocrinol. 2016;174(5):9. doi:10.1530/EJE-16-002326438715
   PubMed Web of Science ®Google Scholar
• Philips BJ, Redman J, Brennan A, et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005;60(9):761–764. doi:10.1136/thx.2004.03576616135681
   PubMed Web of Science ®Google Scholar
• Garnett JP, Baker EH, Naik S, et al. Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax. 2013;68(9):835–845. doi:10.1136/thoraxjnl-2012-20317823709760
   PubMed Web of Science ®Google Scholar